English, Article edition: Economic Evaluation of Treatment Administration Strategies of Ganciclovir for Cytomegalovirus Retinitis in HIV/AIDS Patients in Thailand: A Simulation Study Kanlaya Teerawattananon; Saniorn Iewsakul; Chawewan Yenjitr; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/119443
Physical Description
  • article
Language
  • English

Edition details

Title
  • Economic Evaluation of Treatment Administration Strategies of Ganciclovir for Cytomegalovirus Retinitis in HIV/​AIDS Patients in Thailand: A Simulation Study
Author
  • Kanlaya Teerawattananon
  • Saniorn Iewsakul
  • Chawewan Yenjitr
  • Somsanguan Ausayakhun
  • Watanee Yenjitr
  • Miranda Mugford
  • Yot Teerawattananon
Physical Description
  • article
Notes
  • Background: There are many effective interventions, via various routes (intravenous [IV], oral [OR], intravitreal injection [IVT] and intraocular implantation [IMP]), for treating cytomegalovirus retinitis (CMVR) that have become available. There are large variations in treating CMVR in clinical practice in Thailand. Objective: To evaluate the incremental cost-effectiveness ratio (ICER) of providing (i) IVT, (ii) IV/​OR and (iii) IMP ganciclovir to patients with HIV/​AIDS and CMVR versus providing no treatment. Design: A simulation study for which the input parameters were derived from a systematic review of the literature, a hospital-based survey and patient interviews. Setting: The analysis assumed a Thai healthcare system perspective. However, the model was run using both societal and healthcare provider perspectives. Results: Our results suggest that IVT ganciclovir was cost effective and the best option for treating patients with CMVR irrespective of whether patients received antiretroviral treatment (ART). In patients receiving ART, moving from IVT to IV/​OR ganciclovir was also likely to be a cost-effective option. Offering IMP ganciclovir was not likely to be cost effective. Providing treatments for patients with bilateral CMVR was more cost effective than providing treatments for those with unilateral CMVR, and offering treatments for patients receiving ART was better value for money than treating patients without ART. Conclusions: Our models suggest that IV/​OR ganciclovir should be recommended for the treatment of unilateral and bilateral CMVR for patients receiving ART in the Thai healthcare system. IVT ganciclovir may also have a role in the treatment of CMVR patients not receiving ART.
  • Acquired-immunodeficiency-syndrome, Antiretrovirals, Cost-utility, Cytomegalovirus-retinitis, Ganciclovir
  • RePEc:wkh:phecon:v:25:y:2007:i:5:p:413-428
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment